Document is current
Any future updates will be listed below
-
Authors
García Sebastián, Cristina
Climent Payá, Vicente
Castillo, Juan Carlos
Urbano-Moral, José Ángel
Ruz Zafra, Aurora
Valle Caballero, María José
Zamorano, José Luis
Lobán, Covadonga Fernández-Golfín
Pereda, David Cordero
Álvarez, María Isabel García
Ajo, María
Hurtado, Nick Iván Paredes
Dorado, Ernesto Martín
Urbano, José Ángel
Tamargo, Luis
Guerrero, Franiosco José
Trujillo, Francisco
Chaparro, María Marinela
Pinilla, José Manuel García
Flores, Jesús Piqueras
Belchi, Joaquina
Mogollón, María Victoria
Martínez, Marina
García, Ana
Prat, Susana
Mateo, Irene
Idiazábal, Uxue
Mastracchio, Victoria Piro
Peña, María Luisa
Velasco, Sonia
Rodríguez, Ibón
Limeres, Javier
Palomares, José Rodríguez
Manovel, Ana
Ayala, José María López
Roy, Laura Álvarez
Gil, José María Medina
Marrero, Natalia
Alania, Edgardo
Monzonis, Amparo Martínez
Escudero, Aída
Boing, Irene
-
Funding
Funding for this research was provided by:
Takeda Pharmaceuticals International AG
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Prevalencia de la enfermedad de Fabry en los pacientes con hipertrofia ventricular izquierda e insuficiencia renal (PrEFaCe)
Journal Title: Medicina Clínica
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2024.06.009
Content Type: article
Copyright: © 2024 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
